Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
The Journal of Urology
|
February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled Trial
Michael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
The Journal of Urology
|
June 22, 2026
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes
Tyler S Garman, Soum Lokeshwar, Jack Campbell, et al.
Tomography (Ann Arbor, Mich.)
|
September 22, 2023
Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis
Rubab F Malik, Renu Berry, Brandyn D Lau, et al.
European Urology Open Science
|
November 10, 2022
Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma
Matthew J Rabinowitz, Tina Esfandiary, Joseph Cheaib, et al.
Gynecologic Oncology Reports
|
April 8, 2024
Salpingectomy for ovarian cancer prevention: Video education for the surgeon
Emily MacArthur, Kara Long Roche, Joseph Sakran, et al.
Urologic Oncology
|
January 26, 2024
Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study
Joseph G Cheaib, Ruchika Talwar, Daniel S Roberson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment
Zhuo Tony Su, Isabella S Florissi, Anne E Geller, et al.
Clinical Genitourinary Cancer
|
March 28, 2021
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)
Sunil H Patel, Ithaar H Derweesh, Kazutaka Saito, et al.
Urologic Oncology
|
August 21, 2025
Molecular classification of nonurothelial histologic subtypes of bladder cancer
Michelle I Higgins, Andrew T Gabrielson, Zhuo Tony Su, et al.
Urologic Oncology
|
July 5, 2025
National trends in diagnoses of subtype histologies in bladder cancer: A population-based study based on the SEER database
Brendan K Wallace, Zhuo Tony Su, James P Flynn, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
The Journal of Urology
|
February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled Trial
Michael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
The Journal of Urology
|
June 22, 2026
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes
Tyler S Garman, Soum Lokeshwar, Jack Campbell, et al.
Tomography (Ann Arbor, Mich.)
|
September 22, 2023
Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis
Rubab F Malik, Renu Berry, Brandyn D Lau, et al.
European Urology Open Science
|
November 10, 2022
Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma
Matthew J Rabinowitz, Tina Esfandiary, Joseph Cheaib, et al.
Gynecologic Oncology Reports
|
April 8, 2024
Salpingectomy for ovarian cancer prevention: Video education for the surgeon
Emily MacArthur, Kara Long Roche, Joseph Sakran, et al.
Urologic Oncology
|
January 26, 2024
Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study
Joseph G Cheaib, Ruchika Talwar, Daniel S Roberson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment
Zhuo Tony Su, Isabella S Florissi, Anne E Geller, et al.
Clinical Genitourinary Cancer
|
March 28, 2021
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)
Sunil H Patel, Ithaar H Derweesh, Kazutaka Saito, et al.
Urologic Oncology
|
August 21, 2025
Molecular classification of nonurothelial histologic subtypes of bladder cancer
Michelle I Higgins, Andrew T Gabrielson, Zhuo Tony Su, et al.
Urologic Oncology
|
July 5, 2025
National trends in diagnoses of subtype histologies in bladder cancer: A population-based study based on the SEER database
Brendan K Wallace, Zhuo Tony Su, James P Flynn, et al.
Page
of 6